Dr. Feany

	Department of Pathology
	Brigham and Women's Hospital
	A teaching Affliate of Harvard Medical School
Home About Us Services Research Education Staff For Patient For Medical Professional Alumni Anatomic Pathology Clinical Laboratories Blood Bank Cytogenetics About Our Research CMOP Histopathology Core Virtual Specimen Locator Biospecimen banking Vascular Research Division DGAP Project Center for Uterine Fibroids Residency AP Program CP program Fellowships CME Faculty Residents and Fellows Administration Patient Resources Referral Information Useful Links Referral Information Calendar and Events Education and Training Sign Out Forms Surg Path Manual Powerpath instructions Useful Links

Name and Present Position:

MEL B. FEANY, Pathologist

Address:

Brigham and Women's Hospital, Department of Pathology, 221 Longwood Avenue, Boston, MA

Medical School (including school name, date and degree awarded):

1995 MD, Albert Einstein College of Medicine, Bronx, NY

Graduate Medical Education (including dates and institution of internships, residencies, fellowships, etc.):

1993 PhD, Harvard University, Cambridge, MA
1995-1997 Resident in Anatomic Pathology, Brigham and Women's Hospital
1997-1999 Clinical Fellow in Neuropathology, Brigham and Women's Hospital

Certification:

1999 American Board of Pathology (Anatomic Pathology and Neuropathology)

Current Academic Appointment:

Associate Professor of Pathology, Harvard Medical School, Boston, MA

Current Medical Staff Appointments:

Pathologist, Division of Neuropathology, Brigham and Women's Hospital
Pathology Consultant (Neuropathology), Children's Hospital, Boston, MA

Selected Bibliography:

Feany MB, Quinn WG. A neuropeptide gene defined by the Drosophila memory mutant amnesiac. Science 1995; 268:869-873. (see also accompanying "Perspectives" in same issue)
Feany MB, Dickson DW. Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 1995; 146:1388-1396.
Feany MB, Bender WW, A Drosophila model of Parkinson's disease. Nature 2000; 404:394-398. (see also accompanying "News and Views" in same issue).
Wittmann CW, Wszolek MF, Shulman JM, Salvaterra PM, Lewis J, Hutton M, Feany MB. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 2001 Jun 14 (epub ahead of print). See also accompanying News Article in same issue.
Feany MB. Studying human neurodegenerative diseases in flies and worms. J Neuropathol Exptl Neurol 2000; 59:847-856.
Chen L, Feany MB. a-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat Neurosci 2005;8:657-63.
Khurana V, Lu Y, Steinhilb ML, Oldham S, Shulman JM, Feany MB. TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model. Curr Biol 2006;16:230-41.
Dias-Santagata D, Fulga T, Duttaroy A, Feany MB. Oxidative stress mediates tau-induced neurodegeneration in Drosophila. J Clin Invest 2007;117:236-45.
Fulga T, Elson-Schwab I, Khurana V, Steinhilb ML, Spires TL, Hyman BT, Feany MB. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat Cell Biol 2007;9:139-48.
Periquet M, Fulga T, Myllykangas L, Schlossmacher MG, Feany MB. Aggregation of a-synuclein mediates neurotoxicity in vivo. J Neurosci 2007;27:3338-46.